Long non-coding RNA-422 acts as a tumor suppressor in colorectal cancer.

Biochem Biophys Res Commun

Colorectal Cancer Center, Department of General Surgery, Jiangsu Cancer Hospital, Cancer Research Institute, Cancer hospital of Nanjing Medical University, Nanjing 210009, Jiangsu Province, PR China. Electronic address:

Published: January 2018

Colorectal cancer (CRC) is one of the most frequent cancer in numerous of countries worldwidely. The initiation and progression of CRC is an extremely complex process, and have been suggested a correlation with Long non-coding RNAs (lncRNAs). Our results showed that lncRNA-422(ENST00000415820) significantly downregulated in the tissues and serum of CRC patients, and is closely associated with the poor prognosis. Then gain or loss of lncRNA-422 models in SW480 and SW620cells were established. The results showed that lncRNA-422 overexpression inhibited cell proliferation, migration, and invasion. Knockdown of lncRNA-422 promoted tumorigensis. Western blot and qRT-PCR were performed to examine the activity of the PI3K/AKT/mTOR pathway in CRC cells after alternation of lncRNA-422. Results showed that lncRNA-422 acts as a tumor suppressor by PI3K/AKT/mTOR pathway in CRC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2017.10.076DOI Listing

Publication Analysis

Top Keywords

long non-coding
8
acts tumor
8
tumor suppressor
8
colorectal cancer
8
pi3k/akt/mtor pathway
8
pathway crc
8
crc
5
lncrna-422
5
non-coding rna-422
4
rna-422 acts
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!